Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion description "[Methotrexate and 6-mercaptopurine, important components of acute lymphoblastic leukemia treatment, are substrates for multidrug resistance-associated protein MRP4.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion evidence source_evidence_literature NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion SIO_000772 19515727 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion wasDerivedFrom befree-20140225 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_assertion wasGeneratedBy ECO_0000203 NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP805091.RAVGTi4g5gTZtuQ8uCXxBzPftOyVh62dn5OcY8a-ORjeI130_provenance.